MarketBeat
01 Aug 2026, 00:05 UTC · 13w ago
Impact · against what's priced in
Proto Labs (PRLB) shows strong momentum with record revenue and raised guidance driven by aerospace, defense, and AI infrastructure demand. The growth in larger blue-chip accounts and significant EPS expansion suggests a positive trajectory for the core business.
No priced-in read yet
What the story claims
6 claims · scored −1 bearish … +1 bullish
Proto Labs raised its full-year 2026 revenue growth outlook to 8% to 10% year over year.
So whatRaising full-year guidance is a strong bullish signal indicating management confidence in sustained demand and growth.
More positive than 98% of claims this week
Non-GAAP earnings per share increased 45% year over year to $0.60, the company's highest adjusted EPS since Q3 2020.
Continue reading
5 related stories
The company raised its full-year revenue growth outlook to 8-10% and achieved its highest adjusted EPS since 2020, driven by 13.1% growth in CNC machining and 12.9% in injection molding.
Read from the article alone
No priced-in read yet
The mention of an expanded relationship with Proto Labs is a minor supplier detail that does not materially affect Edwards Lifesciences' valuation.
Read from the article alone
No priced-in read yet
The mention of an expanded relationship with Proto Labs is a minor supplier detail that does not materially affect Lockheed Martin's valuation.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 92% of claims this week
Revenue per customer increased 17% from a year earlier, driven by deeper engagement with larger accounts including Meta, Lockheed Martin, and Medtronic.
More positive than 85% of claims this week
CNC machining and injection molding saw strong growth (13.1% and 12.9% respectively), driven by aerospace, defense, and data center demand.
More positive than 76% of claims this week
Which stocks this story touches
More positive than 99% of ticker scores this week
The company reported record second-quarter revenue, strong profitability, and raised its full-year growth outlook.
More positive than 53% of ticker scores this week
Mentioned as a company with which Proto Labs has expanded or continued a relationship, implying steady business activity.
More positive than 53% of ticker scores this week
Mentioned as a company with which Proto Labs has expanded or continued a relationship, implying steady business activity.
More positive than 53% of ticker scores this week
Mentioned as a company with which Proto Labs has expanded or continued a relationship, implying steady business activity.
More positive than 53% of ticker scores this week
Mentioned as a company with which Proto Labs has expanded or continued a relationship, implying steady business activity.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
24/7 Wall Street
1h ago
More positive than 33% of relationship scores this week
[a_to_b] Proto Labs provides manufacturing services to Lockheed Martin.
More positive than 33% of relationship scores this week
[a_to_b] Proto Labs provides manufacturing services to Medtronic.
More positive than 33% of relationship scores this week
[a_to_b] Proto Labs provides manufacturing services to Meta.
−7.0%
Price is moving against the score
$69.79 vs $75.05 close before publication (Jul 31) · not market-adjusted
PRLB chart →+9.9%
$640.47 vs $582.74 close before publication (Jul 31) · not market-adjusted
LMT chart →+10.2%
$94.83 vs $86.07 close before publication (Jul 31) · not market-adjusted
EW chart →
